Valuation
Is the price right?2/2 inputs reported · High confidence
Weaker than most peers on:
- ▼ P/B
- ▼ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Sep 30, 2026
2/2 inputs reported · High confidence
Weaker than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Weaker than most peers on:
Earnings-per-share growth versus other banks and insurers.
Insufficient data: 1 of 2 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 90.0M USD | 94.0M USD | +4.4% |
| Net income (12 months) | −155.0M USD | −144.0M USD | −7.1% |
| Cash | 72.0M USD | 117.0M USD | +62.5% |
| Shares outstanding | 50.9M | 51.0M | +0.2% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks & Insurance are within their usual range since 2016.
Shown for Banks & Insurance: too few Insurance - Specialty companies have a long enough history of their own.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Net margin | -235.4% | -126.6% | 6814.3% | 1035.7% | -221.3% | ▼ >999 pts |
| Return on assets (ROA) | -9.5% | -5.8% | 18.3% | 20.1% | -8.8% | ▼ 29 pts |
| Return on equity (ROE) | — | — | — | — | — | — |
Price history is added with the daily price update and will appear after the next one.